On January 13, 2026, the National Medical Products Administration (NMPA) of the People's Republic of China released the Cosmetics Decision Letter Delivery Information for that date. This routine administrative disclosure, issued in accordance with China's Cosmetics Supervision and Administration Regulations, publicly announces the delivery of official decision letters for cosmetic product registrations or notifications. The announcement details three cosmetics that received their approval decision letters on January 13, 2026: 1.GHZTCH2500189 (Aiqisi Elastic Perm Lotion) 2.GHZTCH2500190 (Aiqisi Care Straight Perm) 3.GHZTCH2500191 (Hao Aini Whitening and Spot-Removing Cream) These products include hair-perming lotions and a skin whitening cream, likely classified as special-use cosmetics requiring NMPA evaluation and approval for safety, efficacy, and quality compliance. The public notice confirms that the marketing authorisation holders have formally received the decisions, allowing them to proceed with manufacturing, importation, and sales in accordance with Chinese regulations. This transparency measure supports traceability, protects consumer safety by verifying that the products have passed rigorous technical and safety assessments, and reflects NMPA's commitment to efficient regulatory processes while upholding strict standards for product quality, labelling, and market entry.
Consumer News Region